Document is current
Any future updates will be listed below
-
Authors
May, Jori E. https://orcid.org/0000-0001-7744-5700
Lauzon, Steven D.
Godby, Richard C.
Kanter, Julie
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR001450)
National Institute of General Medical Sciences (U54GM104941)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR072582)
- License Information
-
More Information
Article History
Accepted: 5 April 2022
First Online: 19 April 2022
Declarations
:
: SDL is an employee and minority shareholder in Eli Lilly and Company and was employed at Medical University of South Carolina when the statistical analysis was performed. JK is provides consultant for Novartis, Graphite Bio, Fulcrum Therapeutics and Forma Therapeutics (no relevant conflict of interest in this manuscript).
